Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 4 (April)

1. A longitudinal study of drivers with Alzheimer disease.
   Neurology, 70(14): 1171-8. [Abstract] [Full-text]
2. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.
   Neurology, 70(14): 1163-70. [Abstract] [Full-text]
3. Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.
   Proc Natl Acad Sci U S A, 105(13): 5099-104. [Abstract] [Full-text]
4. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
   J Am Geriatr Soc, 56(4): 677-82. [Abstract] [Full-text]
5. Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease.
   J Med Genet, 45(4): 244-8. [Abstract] [Full-text]
6. Change in depressive symptoms during the prodromal phase of Alzheimer disease.
   Arch Gen Psychiatry, 65(4): 439-45. [Abstract] [Full-text]
7. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
   Neurology, 70(15): 1258-64. [Abstract] [Full-text]
8. The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases.
   BMC Geriatr, 8: 7. [Abstract] [Full-text]
9. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.
   JAMA, 299(15): 1813-7. [Abstract] [Full-text]
10. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems.
    Neurology, 70(17): 1534-42. [Abstract] [Full-text]
11. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
    Proc Natl Acad Sci U S A, 105(16): 6027-32. [Abstract] [Full-text]
12. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.
    Physiol Genomics, 33(2): 240-56. [Abstract] [Full-text]
13. BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease.
    Neurobiol Aging, 29(6): 861-73. [Abstract] [Full-text]
14. Megalin mediates the transport of leptin across the blood-CSF barrier.
    Neurobiol Aging, 29(6): 902-12. [Abstract] [Full-text]
15. Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.
    Neurobiol Aging, 29(6): 874-81. [Abstract] [Full-text]
16. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?
    Neurobiol Aging, 29(6): 795-811. [Abstract] [Full-text]
17. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
    Neurobiol Aging, 29(6): 819-27. [Abstract] [Full-text]
18. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
    Neurobiol Aging, 29(6): 836-47. [Abstract] [Full-text]
19. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.
    Neurobiol Aging, 29(6): 812-8. [Abstract] [Full-text]
20. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease.
    Neurobiol Aging, 29(6): 848-55. [Abstract] [Full-text]
21. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
    Neurobiol Aging, 29(6): 856-60. [Abstract] [Full-text]
22. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease.
    Neurobiol Aging, 29(6): 891-901. [Abstract] [Full-text]
23. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
    Proc Natl Acad Sci U S A, 105(17): 6415-20. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.